YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Marksans Pharma

BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
Mar 23, 16:00
-1.95 (-5.83%)
VOLUME 748,519
Mar 23, 15:59
-1.95 (-5.84%)
VOLUME 4,877,322
Announcements on Marksans Pharma

14th-Mar-2018 15:13Source: BSE

Marksans Pharma- Announcement under Regulation 30 (LODR)-Change in Directorate

Appointment of Mr. Digant Mahesh Parikh as Independent Director

12th-Feb-2018 13:04Source: NSE

Marksans Pharma Limited

Marksans Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

12th-Feb-2018 12:42Source: BSE

Marksans Pharma- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release dated 12.02.2018

12th-Feb-2018 12:36Source: BSE

Marksans Pharma- Board Meeting-Outcome of Board Meeting

Sub: Unaudited Financial Results for the quarter ended 31st December, 2017 and Limited Review Reports thereon.

Dear Sir,

In terms of Regulation 33 of the SEBI (Listing Obligation an...

2nd-Feb-2018 15:48Source: BSE

Marksans Pharma- Closure of Trading Window

Dear Sir,

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Monday, 12th February, 2018 at Mumbai, to consider and approve the Unaudited Financi...

2nd-Feb-2018 15:42Source: BSE

Marksans Pharma- Board Meeting On 12.02.2018

Board Meeting on 12.02.2018

19th-Jan-2018 11:32Source: BSE

Marksans Pharma- Shareholding for the Period Ended December 31, 2017

Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly

10th-Jan-2018 10:53Source: BSE

Marksans Pharma- Statement Of Investor Complaints For The Quarter Ended December, 2017

Statement of Investor Complaints for the quarter ended December, 2017 under Regulation 13(3) of SEBI (LODR), 2015.

5th-Jan-2018 12:20Source: BSE

Marksans Pharma- Credit Rating

Intimation of Revision in Credit Ratings of Marksans Pharma Limited by Fitch Group.

3rd-Jan-2018 14:39Source: NSE

Marksans Pharma Limited

Marksans Pharma Limited has informed the Exchange regarding Change in Director(s) of the company. Mr. Naresh Wadhwa has resigned as Director of the Company.

1 2 3 4 5 Next >>
Quick Links for Marksans Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.